Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q104131807> ?p ?o ?g. }

Showing items 1 to 74 of 74 with 100 items per page.

Q104131807 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 4ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
Q104131807 description "article scientifique publié en 2020" @default.
Q104131807 description "artículu científicu espublizáu n'avientu de 2020" @default.
Q104131807 description "scientific article published on 04 December 2020" @default.
Q104131807 description "wetenschappelijk artikel" @default.
Q104131807 description "наукова стаття, опублікована 4 грудня 2020" @default.
Q104131807 name "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 name "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 name "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 type Item @default.
Q104131807 label "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 label "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 label "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 prefLabel "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 prefLabel "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 prefLabel "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 P1433 Q104131807-2ECDBA70-F833-45DA-91C9-318687726B44 @default.
Q104131807 P1476 Q104131807-08CBE535-62F0-4E1D-8657-3A5D13A505BF @default.
Q104131807 P2093 Q104131807-102D2C89-1233-46CE-BC64-937CEBB8704F @default.
Q104131807 P2093 Q104131807-2FF71934-C144-446B-9D2C-D58B79FC2C4A @default.
Q104131807 P2093 Q104131807-5417CE6F-9DC8-48B6-A62A-87A4125A0916 @default.
Q104131807 P2093 Q104131807-B1B8017E-030A-41B3-983E-32465BB96C5A @default.
Q104131807 P275 Q104131807-13fd451c-9870-4761-88ad-946d7dd3232c @default.
Q104131807 P31 Q104131807-A7316469-42E7-4347-AD8E-02AE03286C85 @default.
Q104131807 P356 Q104131807-980E24F0-2E1F-4320-9C1B-D0790A54998E @default.
Q104131807 P433 Q104131807-7DCDB310-B219-4513-8306-B8A70D6D56AC @default.
Q104131807 P478 Q104131807-5154E0B3-F3FF-461E-975F-F437C0F3C1D1 @default.
Q104131807 P50 Q104131807-0645612A-30FD-4F57-A5F9-52EF89C1DBDA @default.
Q104131807 P50 Q104131807-126052FA-6CAB-4F2F-B2DF-5DBAF2079DF2 @default.
Q104131807 P50 Q104131807-16D6F247-139D-4EC5-89BA-B9B7EB343126 @default.
Q104131807 P50 Q104131807-1919E81E-7CD3-4D66-9A26-A920FE739169 @default.
Q104131807 P50 Q104131807-3308DA0E-B403-45A0-9953-25E4B186DE2B @default.
Q104131807 P50 Q104131807-37A9043F-8D12-4025-A323-5E7B8DE3394D @default.
Q104131807 P50 Q104131807-5658118F-89CC-48F9-BCC4-5B7B3CC05A09 @default.
Q104131807 P50 Q104131807-89CD9B9C-791D-402A-80CD-40FEA57E04CC @default.
Q104131807 P50 Q104131807-D6953C6B-9494-479F-A6E8-AA0F65EAC52B @default.
Q104131807 P50 Q104131807-D82BCFD0-C17D-4AD1-969A-AF34EF03170C @default.
Q104131807 P50 Q104131807-F5772696-DE32-496E-B58F-794E698E0CC1 @default.
Q104131807 P50 Q104131807-F7285197-80C5-4720-86FF-2AC4AE9BDEF2 @default.
Q104131807 P577 Q104131807-30371D1C-D963-4FFB-AAAA-0AF394941374 @default.
Q104131807 P6216 Q104131807-0f64f593-b810-40eb-988d-5a0e855818e8 @default.
Q104131807 P698 Q104131807-D9B11D16-73A4-48EF-B33C-F029E913D01B @default.
Q104131807 P921 Q104131807-3309EC03-321D-4A37-9647-7C8B4425D2AA @default.
Q104131807 P932 Q104131807-65C9C38B-1CD3-422A-82E9-1DA3C80E1E31 @default.
Q104131807 P356 PHARMACEUTICS12121181 @default.
Q104131807 P698 33291738 @default.
Q104131807 P1433 Q27723332 @default.
Q104131807 P1476 "Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations" @default.
Q104131807 P2093 "Ana Teresa Serra" @default.
Q104131807 P2093 "António Ferreira" @default.
Q104131807 P2093 "Rui Pinto" @default.
Q104131807 P2093 "Sandra Simões" @default.
Q104131807 P275 Q20007257 @default.
Q104131807 P31 Q13442814 @default.
Q104131807 P356 "10.3390/PHARMACEUTICS12121181" @default.
Q104131807 P433 "12" @default.
Q104131807 P478 "12" @default.
Q104131807 P50 Q117236484 @default.
Q104131807 P50 Q37837571 @default.
Q104131807 P50 Q39051685 @default.
Q104131807 P50 Q39460608 @default.
Q104131807 P50 Q43081462 @default.
Q104131807 P50 Q46385580 @default.
Q104131807 P50 Q50208187 @default.
Q104131807 P50 Q51128473 @default.
Q104131807 P50 Q55173190 @default.
Q104131807 P50 Q55174391 @default.
Q104131807 P50 Q55344661 @default.
Q104131807 P50 Q57617389 @default.
Q104131807 P577 "2020-12-04T00:00:00Z" @default.
Q104131807 P6216 Q50423863 @default.
Q104131807 P698 "33291738" @default.
Q104131807 P921 Q22701 @default.
Q104131807 P932 "7761993" @default.